Strategy

Oct 09, 2013
Real-world pharmacoeconomic data can provide critical insight for maximizing US market access and oncology product differentiation, and should be central to the overall brand strategy of any oncology product
Oct 01, 2013
Pharmaceutical Executive
New drug delivery mechanisms and devices are an opportunity to build relationship with the ultimate customer: the patient.
Sep 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided.
Sep 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Companies are leveraging combinations of drugs and other products to gain competitive advantage and market share.
Sep 01, 2013
Pharmaceutical Executive
What it takes for promotional review teams to function at their best and avoid costly mistakes.
Aug 01, 2013
Pharmaceutical Executive
As growth in the BRICs and other emerging economies begins to stabilize, companies are finally turning their attention to Africa—a hidden trove of potential that is only as good as you make it.
Aug 01, 2013
Pharmaceutical Executive
Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate.
Jul 01, 2013
Pharmaceutical Executive
The lifeblood of the life sciences industry is continuous innovation—it is not a business that can survive by standing still.
Jun 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage.
Jun 01, 2013
Pharmaceutical Executive
New stakeholders, innovative technologies, and emergent synergies in government are combining to build fresh momentum behind the old issue of medication adherence. The question is will Big Pharma be flexible enough to keep pace with the changes?
native1_300x100
lorem ipsum